Relationship between the expression level of HER-2 and the prognosis of patients with gastric cancer in the same pathological stage
10.3760/cma.j.issn.1673-4203.2012.07.005
- VernacularTitle:HER-2基因表达水平与相同病理分期胃癌患者预后的关系
- Author:
Maorong LIU
;
Shuliang LI
;
Xukun Lü
;
Hengling GAO
;
Bo ZHANG
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Pathology;
Neoplasm staging;
Prognosis;
HER-2
- From:
International Journal of Surgery
2012;39(7):444-446,505
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo study the expression level of HER-2 gene in the same pathological stage gastric cancer,and discuss the feasibility of HER-2 gene being the prognostic indicator.MethodsThe expression of HER-2 in gastric cancer was detected by immunohistocehmical technique and analyzed in relation with the pathological stage and prognosis of the patients.ResultsThe total positive rate of HER-2 in gastric cancer was 33.64% (37/110).In stage Ⅱ,the weakly and strongly positive rates of gastric cancer were 21.31% ( 13/61 ) and 9.84% (6/61).In stage Ⅲ,the weakly and strongly positive rates of gastric cancer were 20.41% (10/49) and 16.33% (8/49).In the same pathological stage,the survival rate of patients with negative HER-2 expression was higher than weakly positive ones.And the survival rate of patients with strongly positive HER-2 expression was the lowest.The difference had statistical significance (P < 0.01).ConclusionThe prognosis of patients in the same stage was correlated with the expression level of HER-2,which can be used to evaluate the biological behavior and prognosis of gastric cancer.